[india-drug] Response to action regarding Mifepristone

[Sunil Kaul <scowl@satyam.net.in>]

Response to action regarding Mifepristone
-----------------------------------------

THANK YOU SO MUCH

sunil


Ward 10, B O C Gate
Bongaigaon (N)
Assam 783 380
theant1@rediffmail.com
PLEASE NOTE CHANGE IN Phone :03664 225506




-----Original Message-----
Subject: [india-drug] Response to Mifepristone



Response to Mifepristone
------------------------

Dear Sunil,
You will be happy to know that consequent to the complaint filed by our
faculty, Dr Kabra, The Human Rights Commission ,Rajasthan has issued
notices to the Drugs control authorities to take action in this regard.
Jawahar S Bapna, MD, Ph.D
----------------------------------------------
Professor, Health & Pharmaceutical Management
Indian Institute of Health Management Research
1, Prabhudayal Marg, Airport Road
Jaipur 302 011
Phone  (O) 2791431, (H) 2620828; Fax 2792138
email: jbapna@iihmr.org




________________________________________________________________________
Missed your favourite TV serial last night? Try the new, Yahoo! TV.
       visit http://in.tv.yahoo.com
The INDIA-DRUG discussion group is a partnership between SATELLIFE
(www.healthnet.org), WHO Essential Drugs and Medicines Policy
(www.who.ch), and the Delhi Society for the Promotion of the
Rational Use of Drugs (DSPRUD) in India.

To send a message to india-drug, write to: india-drug@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe india-drug OR unsubscribe india-drug
To contact a person, send a message to: india-drug-help@usa.healthnet.org